Globus Medical rises after Q3 results beat

Globus Medical

07/11/2025 14:01

** Shares of medical device maker Globus Medical GMED.N rise 28.8% to $79.47 premarket

** Co late on Thursday posted Q3 sales of $769 million, beating analysts' estimate of $734.35 million, according to LSEG compiled data

** CEO Keith Pfeil said Q3 revenue jumped 23%, driven by 10% growth in its US Spine business, as momentum accelerated with broadbased demand across the company's products and geographies

** Co reported Q3 adj. profit of $1.18 per share vs. an estimate of 78 cents per share

** As of last close, GMED stock was down 25.4% YTD

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com))